Articles From: QEP Resources Reports Estimated Fourth Quarter and Full Year 2012 Financial and Operating Results to QlikTech Customer LARSON Manufacturing Company Named a Winner of the 2013 Manufacturing Leadership 100 Awards

QEP Resources, Inc. (NYSE: QEP) ("QEP" or the "Company"), today reported estimated fourth quarter and full year 2012 financial and operating results.

QEP Resources, Inc. (NYSE: QEP) ("QEP" or the "Company") today reported first quarter 2013 financial and operating results.

QEP Resources, Inc. (NYSE: QEP) , a leading independent natural gas and crude oil exploration and production company, today announced that its Board of Directors approved a quarterly cash dividend of $0.02 per share payable on March 7, 2013, to shareholders of record on February 25, 2013.

HILDEN , Germany and REDWOOD CITY, California , April 29, 2013 /PRNewswire/ -- Ingenuity Systems is the global market leader in applications to quickly analyze and accurately interpret rapidly growing volumes of genomic data Suite of web-based applications powered by a unique expert-curated Knowledge Base eases major bottlenecks to leveraging genomic data in research and clinical diagnostics Adds leading biological interpretation resources to QIAGEN's ecosystem of sample-to-result molecular testing solutions using key technologies such as real-time PCR and next-generation sequencing (NGS) Deepens insights into disease, augmenting successful GeneGlobe content offering   QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of Ingenuity Systems, Inc., the leading provider of software solutions to efficiently and accurately analyze and interpret the

GERMANTOWN, Maryland and HILDEN, Germany , February 13, 2013 /PRNewswire/ -- Arrangement to facilitate future collaborations in personalized medicine Provides framework to develop and commercialize QIAGEN companion diagnostics paired with Lilly medicines in an effort to improve outcomes for individual patients Builds on the two companies' recent mutual successes QIAGEN (NASDAQ: QGEN; Frankfurt , Prime Standard: QIA) today announced it has entered into a master collaboration agreement with Eli Lilly and Company (NYSE: LLY) for the development and commercialization of companion diagnostics for pairing with Lilly investigational and approved medicines across all therapeutic areas.

VENLO, The Netherlands, April 15, 2013 (GLOBE NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN) today reconfirmed plans to release its report on results for the first quarter of 2013 on Monday, April 29, at 22:00 Central European Time (CET) / 16:00 Eastern Time (ET). Also as previously announced, a webcast is planned for Tuesday, April 30, at 15:30 CET / 9:30 ET that will include remarks by Peer M.

VENLO, Netherlands, May 15, 2013 (GLOBE NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) has posted its 2012 Annual Report on its website at http://www.qiagen.com/About-Us/Investors/Financial-Information/Financial-Reports .

VENLO, the Netherlands , April 29, 2013 /PRNewswire/ -- Prof.

VENLO, The Netherlands , April 29, 2013 /PRNewswire/ -- Achieves Q1 2013 targets: Net sales of $303.6 million grow 3% CER on expansion in all regions; adjusted diluted EPS at $0.23 per share; free cash flow of $30 million Progress   to ward accelerating innovation and growth in 2013: Molecular Diagnostics (+11% CER) and Applied Testing (+5% CER) deliver solid results, more than offset weak market conditions in Pharma and Academia QIAsymphony au to mation platform well on track   to   surpass 1,000 cumulative placements during 2013; new QIAlink software provides interface   to   labora to ry information management systems Acquisition of Ingenuity Systems, global leader in analysis and interpretation of complex biological data, adds   to   QIAGEN's ecosystem for molecular testing Advancing more than 35 diagnostic

MARCO ISLAND, Florida , and HILDEN, Germany , February 20, 2013 /PRNewswire/ -- Streamlined and automated NGS workflow will offer many features required to enable routine use in clinical applications Building on strengths in Sample & Assay Technologies to create an integrated NGS ecosystem with sample processing, genomic testing and bioinformatics New consumable products address critical workflow challenges, expanding QIAGEN's portfolio of "universal" solutions for use on any NGS system QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today provided new insights into its next-generation sequencing (NGS) initiative, unveiling an innovative sample-to-result NGS workflow designed to enable the routine use of this breakthrough technology beyond life sciences research in areas such as clinical research and diagnostics.

HILDEN , Germany and GERMANTOWN, Maryland , January 30, 2013 /PRNewswire/ -- Momentum builds for   therascreen ® KRAS RGQ PCR Kit   and Rotor-Gene Q MDx instrument Clarient offers network of 2,000-plus pathologists testing with   therascreen     KRAS RGQ PCR Kit, the only FDA-approved KRAS companion diagnostic for Erbitux ® in metastatic colorectal cancer KRAS launch prepares way for QIAGEN's growing pipeline of Personalized Healthcare content QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that Clarient - a GE Healthcare Company and leading provider of cancer laboratory testing services in the United States - has adopted the use of the therascreen ® KRAS RGQ PCR Kit ( therascreen KRAS test) as a companion diagnostic to guide the use of Erbitux ® (cetuximab) as a treatment in patients with metastatic colorectal

BEIJING , April 19, 2013 /PRNewswire/ -- Qihoo 360 Technology Co.

BEIJING , March 5, 2013 /PRNewswire/ -- Qihoo 360 Technology Co.

BEIJING , May 7, 2013 /PRNewswire/ -- Qihoo 360 Technology Co.

BEIJING , Feb.

BEIJING , Feb.

MOSCOW, May 8, 2013 (GLOBE NEWSWIRE) -- QIWI plc (Nasdaq:QIWI) , a leading provider of next generation payment services in Russia and the CIS, today announced it has closed its previously announced initial public offering of 12,500,000 Class B Shares in the form of American Depositary Shares (ADS) at a price of $17.00 per ADS.

-- 1Q13 Revenue Decreased 13.4% to $97.1 million from $112.0 million in 1Q12 -- --

DAQING, China , April 15, 2013 /PRNewswire/ -- QKL Stores Inc. (the "Company") (Nasdaq: QKLS) , a leading regional supermarket chain in Northeastern China and Inner Mongolia, today announced its financial results for the fourth quarter and full year financial results ended December 31, 2012 .

DAQING, China , May 13, 2013 /PRNewswire/ -- QKL Stores Inc. (the "Company") (Nasdaq: QKLS) , a leading regional supermarket chain in Northeastern China , today announced that the Company will report its first quarter 2013 financial results before the market open on Tuesday, May 14, 2013 .

DAQING, China , Feb.

DAQING, China , Feb.

QlikTech, (NASDAQ: QLIK ) a leader in Business Discovery – user-driven Business Intelligence (BI), today announced it has appointed Palo Alto Networks’ CFO Steffan Tomlinson to its Board of Directors, effective immediately.

Qlik Technologies Inc. (“QlikTech”) (Nasdaq: QLIK) , a leader in Business Discovery — user-driven Business Intelligence (BI), today announced it will report its first quarter 2013 financial results after the U.S. financial markets close on Thursday, April 25, 2013.

Qlik Technologies Inc. (“QlikTech”) (Nasdaq: QLIK) , a leader in Business Discovery — user-driven Business Intelligence (BI), today announced financial results for the first quarter ended March 31, 2013.

Qlik Technologies Inc. (“QlikTech”) (Nasdaq: QLIK) , a leader in Business Discovery — user-driven Business Intelligence (BI), today announced financial results for the fourth quarter and full year ended December 31, 2012.

Qlik Technologies Inc. ("QlikTech") (Nasdaq: QLIK) , a leader in Business Discovery—user-driven Business Intelligence (BI), today announced its presentation times have been revised at the following upcoming conferences in May.

Qlik Technologies Inc. (NASDAQ: QLIK ) has acquired NComVA AB, a Swedish company specializing in advanced visualization technology.

QlikTech , (NASDAQ: QLIK ) a leader in Business Discovery – user-driven Business Intelligence (BI), today announced that Astellas Pharma US, Inc., a QlikTech customer, was named a Ventana Research 2013 Leadership Award Winner for Business Intelligence.

QlikTech , (NASDAQ: QLIK ) a leader in Business Discovery – user-driven Business Intelligence (BI), today announced that LARSON Manufacturing Company, a QlikTech customer, was named a winner of the 2013 Manufacturing Leadership 100 Awards (ML100). Through successful implementation of QlikView, LARSON was recognized as an outstanding performer in the Information Leadership category.